Literature DB >> 12114913

False-positive serum human chorionic gonadotropin results: causes, characteristics, and recognition.

Glenn D Braunstein1.   

Abstract

False-positive serum human chorionic gonadotropin results are estimated to occur in 1 in 10(3) to 1 in 10(4) tests. Most of these false-positive results are due to interference by non-human chorionic gonadotropin substances (especially human luteinizing hormone and anti-animal immunoglobulin antibodies) and the detection of pituitary human chorionic gonadotropin. The false-positive human chorionic gonadotropin measurements are characterized by serum levels that are generally <1000 mIU/mL, the absence of human chorionic gonadotropin in the urine, nonparallelism of the human chorionic gonadotropin levels in serial dilutions of the serum with the human chorionic gonadotropin standard, results that are not consistent with the clinical or operative findings, the absence of a substantial change in the serum levels over time or after therapy, and the finding of a negative result when an alternative type of human chorionic gonadotropin assay is used. An algorithm is presented to aid in the recognition of false-positive human chorionic gonadotropin results in patients.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12114913     DOI: 10.1067/mob.2002.124284

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  11 in total

1.  A pelvic mass on ultrasonography and high human chorionic gonadotropin level: not always an ectopic pregnancy.

Authors:  Alexandre Rozenholc; Jasmine Abdulcadir; Marie-Françoise Pelte; Patrick Petignat
Journal:  BMJ Case Rep       Date:  2012-06-01

2.  Thalidomide use in the US : experience with pregnancy testing in the S.T.E.P.S. programme.

Authors:  Kathleen Uhl; Edward Cox; Rose Rogan; Jerome B Zeldis; Dena Hixon; Lesley-Anne Furlong; Sarah Singer; Tracy Holliman; Joanne Beyer; William Woolever
Journal:  Drug Saf       Date:  2006       Impact factor: 5.606

3.  Pregnancy, malignancy or mother nature? Persistence of high hCG levels in a perimenopausal woman.

Authors:  Ayşe Y Demir; Ruben Ea Musson; Willem A Schöls; Jitze M Duk
Journal:  BMJ Case Rep       Date:  2019-01-03

4.  Biological relevance of trophectoderm morphology: initial β-hCG measurements correlate with trophectoderm grading on euploid frozen embryo transfers.

Authors:  Carlos Hernandez-Nieto; Joseph Lee; Tamar Alkon-Meadows; Christine Briton-Jones; Benjamin Sandler; Alan Copperman; Tanmoy Mukherjee
Journal:  J Assist Reprod Genet       Date:  2022-06-25       Impact factor: 3.357

5.  The Role of Human Chorionic Gonadotropin Beta (hCGβ) in HPV-Positive and HPV-Negative Oropharyngeal Squamous Cell Carcinoma.

Authors:  Anni Sjöblom; Timo Carpén; Ulf-Håkan Stenman; Lauri Jouhi; Caj Haglund; Stina Syrjänen; Petri Mattila; Antti Mäkitie; Jaana Hagström
Journal:  Cancers (Basel)       Date:  2022-06-08       Impact factor: 6.575

6.  The usefulness of testosterone administration in identifying false-positive elevation of serum human chorionic gonadotropin in patients with germ cell tumor.

Authors:  Akitoshi Takizawa; Koji Kawai; Takashi Kawahara; Takahiro Kojima; Satoru Maruyama; Nobuo Shinohara; Shusuke Akamatsu; Tomomi Kamba; Terukazu Nakamura; Osamu Ukimura; Ryosuke Jikuya; Takeshi Kishida; Kenichi Kakimoto; Kazuo Nishimura; Toru Harabayashi; Satoshi Nagamori; Shinichi Yamashita; Yoichi Arai; Yoshitomo Sawada; Noritoshi Sekido; Hidefumi Kinoshita; Tadashi Matsuda; Tohru Nakagawa; Yukio Homma; Hiroyuki Nishiyama
Journal:  J Cancer Res Clin Oncol       Date:  2017-09-13       Impact factor: 4.553

7.  False-positive beta-human chorionic gonadotropin values in the follow-up of gestational trophoblastic disease.

Authors:  V M Díaz Muñoz de la Espada; J A Arranz Arija; P Khosravi Shahi; S Encinas García; R Alvarez Alvarez; R González Beca
Journal:  Clin Transl Oncol       Date:  2007-05       Impact factor: 3.405

8.  The efficacy and toxicity of 4-day chemotherapy with methotrexate, etoposide and actinomycin D in patients with choriocarcinoma and high-risk gestational trophoblastic neoplasia.

Authors:  Shizuka Sato; Eiko Yamamoto; Kaoru Niimi; Kazuhiko Ino; Kimihiro Nishino; Shiro Suzuki; Tomomi Kotani; Hiroaki Kajiyama; Fumitaka Kikkawa
Journal:  Int J Clin Oncol       Date:  2019-09-13       Impact factor: 3.402

Review 9.  Pituitary as a Source of HCG: Residual Levels After Bilateral Testicular Tumor Removal.

Authors:  Richard Santen; Farhad Hasan; Katie Thoren; Azeez Farooki
Journal:  J Investig Med High Impact Case Rep       Date:  2019 Jan-Dec

Review 10.  A rational diagnostic approach to the "phantom hCG" and other clinical scenarios in which a patient is thought to be pregnant but is not.

Authors:  Oluwafunmilayo Oyatogun; Mandeep Sandhu; Stephanie Barata-Kirby; Erin Tuller; Danny J Schust
Journal:  Ther Adv Reprod Health       Date:  2021-06-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.